One recent study demonstrated that EMP3 has oncogenic properties in high‐grade glioma (HGG), and its overexpression might also predict poor clinical prognosis in primary glioblastoma multiforme (GBM).22, 23. This evidence concerns the gene EMP3 and glioblastoma.